2024
SJR Q1
Journal detail
Drug Discovery Today: Technologies
- Publisher
- Elsevier Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
17406749
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,223
- Quartile Q1
- H-Index 68
- Cites/doc 0
- Docs (3y) 24
- Cites (3y) 107
Clarivate
Web of Science · JCR
No JCR match
Subject classification
Categories (SJR)
- Biotechnology Q1
- Drug Discovery Q1
- Molecular Medicine Q2
Areas
- Biochemistry, Genetics and Molecular Biology
- Pharmacology, Toxicology and Pharmaceutics
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2024 | Q1 | — | 1,223 | — | — | — | — | 68 |
| 2023 | Q1 | — | 1,241 | — | — | — | — | 68 |
| 2022 | Q1 | — | 1,34 | — | — | — | — | 68 |
| 2021 | Q1 | — | 1,321 | — | — | — | — | 68 |
| 2020 | Q1 | — | 1,676 | — | — | — | — | 68 |
| 2019 | Q1 | — | 1,162 | — | — | — | — | 68 |
| 2017 | Q2 | — | 0,822 | — | — | — | — | 68 |
| 2016 | Q1 | — | 0,99 | — | — | — | — | 68 |
| 2015 | Q1 | — | 1,009 | — | — | — | — | 68 |
| 2014 | Q2 | — | 0,928 | — | — | — | — | 68 |
| 2013 | Q2 | — | 0,741 | — | — | — | — | 68 |
| 2012 | Q2 | — | 0,593 | — | — | — | — | 68 |
| 2011 | Q3 | — | 0,414 | — | — | — | — | 68 |
| 2010 | Q3 | — | 0,193 | — | — | — | — | 68 |